ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
26 nov. 2024 16h30 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and...
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
08 nov. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
Generated record quarterly net revenues of $148.3 million, representing year-over-year growth of 12.5%, and record Purified Cortrophin® Gel net revenues of $52.6 million, an increase of 76.8%...
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
04 nov. 2024 16h30 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and...
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
30 oct. 2024 17h00 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial...
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
25 oct. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug...
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
24 oct. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will present new pre-clinical data highlighting its...
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
26 sept. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug...
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
16 sept. 2024 08h53 HE
|
ANI Pharmaceuticals, Inc.
Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basisAdds two durable commercial assets ILUVIEN® and YUTIQ® with...
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
16 sept. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the...
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
13 sept. 2024 06h50 HE
|
ANI Pharmaceuticals, Inc.
PRINCETON, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Promethazine Hydrochloride and Dextromethorphan...